Atlas Trials

Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

Clinical trial NCT02830477 · COMPLETED

Trial details

NCT number
NCT02830477
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Hemophilia A, Congenital
Start date
2016-10-14
Primary completion
2020-12-01
Enrollment
313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.